Glycogen Synthase Kinase 3β: A New Gold Rush in Anti-Alzheimer’s Disease Multitarget Drug Discovery?: Miniperspective

por De Simone, Angela, Tumiatti, Vincenzo, Andrisano, Vincenza, Milelli, Andrea
Publicado 2020

Investigating in Vitro Amyloid Peptide 1–42 Aggregation: Impact of Higher Molecular Weight Stable Adducts

por De Simone, Angela, Naldi, Marina, Tedesco, Daniele, Milelli, Andrea, Bartolini, Manuela, Davani, Lara, Widera, Darius, Dallas, Mark L., Andrisano, Vincenza
Publicado 2019

Amaryllidaceae Alkaloids as Potential Glycogen Synthase Kinase-3β Inhibitors

por Hulcová, Daniela, Breiterová, Kateřina, Siatka, Tomáš, Klímová, Kamila, Davani, Lara, Šafratová, Marcela, Hošťálková, Anna, De Simone, Angela, Andrisano, Vincenza, Cahlíková, Lucie
Publicado 2018

Naturally Inspired Molecules as Multifunctional Agents for Alzheimer’s Disease Treatment

por Rampa, Angela, Tarozzi, Andrea, Mancini, Francesca, Pruccoli, Letizia, Di Martino, Rita Maria Concetta, Gobbi, Silvia, Bisi, Alessandra, De Simone, Angela, Palomba, Francesco, Zaccheroni, Nelsi, Belluti, Federica
Publicado 2016

Derivatives of the β-Crinane Amaryllidaceae Alkaloid Haemanthamine as Multi-Target Directed Ligands for Alzheimer’s Disease

por Kohelová, Eliška, Peřinová, Rozálie, Maafi, Negar, Korábečný, Jan, Hulcová, Daniela, Maříková, Jana, Kučera, Tomáš, Martínez González, Loreto, Hrabinova, Martina, Vorčáková, Katarina, Nováková, Lucie, De Simone, Angela, Havelek, Radim, Cahlíková, Lucie
Publicado 2019